Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors
- PMID: 21425136
- DOI: 10.1002/cncr.25685
Catechol-O-methyltransferase genotype modulates cancer treatment-related cognitive deficits in breast cancer survivors
Abstract
Background: Recent attention has focused on the negative effects of chemotherapy on the cognitive performance of cancer survivors. The current study examined modification of this risk by catechol-O-methyltransferase (COMT) genotype based on evidence in adult populations that the presence of a Val allele is associated with poorer cognitive performance.
Methods: Breast cancer survivors treated with radiotherapy (n = 58), and/or chemotherapy (n = 72), and 204 healthy controls (HCs) completed tests of cognitive performance and provided saliva for COMT genotyping. COMT genotype was divided into Val carriers (Val+; Val/Val, Val/Met) or COMT-Met homozygote carriers (Met; Met/Met).
Results: COMT-Val+ carriers performed more poorly on tests of attention, verbal fluency, and motor speed relative to COMT-Met homozygotes. Moreover, COMT-Val+ carriers treated with chemotherapy performed more poorly on tests of attention relative to HC group members who were also Val+ carriers.
Conclusions: The results suggest that persons treated with chemotherapy for breast cancer who also possess the COMT-Val gene are susceptible to negative effects on their cognitive health. This research is important because it strives to understand the factors that predispose some cancer survivors to more negative quality-of-life outcomes.
Copyright © 2010 American Cancer Society.
Similar articles
-
Catechol-O-methyltransferase genotype (Val158met) modulates cancer-related fatigue and pain sensitivity in breast cancer survivors.Breast Cancer Res Treat. 2012 Jun;133(2):405-12. doi: 10.1007/s10549-011-1757-y. Epub 2011 Sep 4. Breast Cancer Res Treat. 2012. PMID: 21898113
-
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.Cancer Res. 1997 Dec 15;57(24):5493-7. Cancer Res. 1997. PMID: 9407957
-
Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.Oncol Rep. 2005 Sep;14(3):707-12. Oncol Rep. 2005. PMID: 16077979
-
The genetic variants underlying breast cancer treatment-induced chronic and late toxicities: a systematic review.Cancer Treat Rev. 2014 Dec;40(10):1199-214. doi: 10.1016/j.ctrv.2014.10.001. Epub 2014 Oct 14. Cancer Treat Rev. 2014. PMID: 25458605
-
Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.Ann Oncol. 2019 Dec 1;30(12):1925-1940. doi: 10.1093/annonc/mdz410. Ann Oncol. 2019. PMID: 31617564 Free PMC article. Review.
Cited by
-
Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.Med Sci Monit. 2020 Sep 28;26:e923567. doi: 10.12659/MSM.923567. Med Sci Monit. 2020. PMID: 32985495 Free PMC article.
-
Genetics and functional imaging: effects of APOE, BDNF, COMT, and KIBRA in aging.Neuropsychol Rev. 2015 Mar;25(1):47-62. doi: 10.1007/s11065-015-9279-8. Epub 2015 Feb 10. Neuropsychol Rev. 2015. PMID: 25666727 Review.
-
Clinical and genetic factors associated with self-reported cognitive deficits in women with breast cancer: the "CAGE-Cog" study.BMC Cancer. 2022 Sep 19;22(1):996. doi: 10.1186/s12885-022-10077-6. BMC Cancer. 2022. PMID: 36123640 Free PMC article.
-
Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.Breast Cancer. 2021 Jan;28(1):236-245. doi: 10.1007/s12282-020-01168-y. Epub 2020 Oct 8. Breast Cancer. 2021. PMID: 33030667
-
Pharmacogenetics of taxane-induced neurotoxicity in breast cancer: Systematic review and meta-analysis.Clin Transl Sci. 2022 Oct;15(10):2403-2436. doi: 10.1111/cts.13370. Epub 2022 Aug 17. Clin Transl Sci. 2022. PMID: 35892315 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous